The Infinium Global Research analyzes the Allergic Rhinitis Market over the period of 2020 to 2026. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global allergic rhinitis market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of allergic rhinitis. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the allergic rhinitis market during the period.
"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026." The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/24671
Rise in Awareness About Allergic Rhinitis Due to Several Government Initiatives are Also Propelling the Growth of the Allergic Rhinitis Drugs Market
The worldwide prevalence of allergic rhinitis has witnessed a significant rise, with the regional prevalence rates varying from 10%-45%. The increasing prevalence could be attributed to increased exposure to allergens, irritants, and pollutants. Currently, 40% of children and 10 to 30% of adults are affected by allergic rhinitis. The European Community Respiratory Health survey recorded a prevalence of 10 to 41% in adults with allergic rhinitis.
Furthermore, an increase in exposure to vehicular pollution, animal dander, or pollen will lead to more people seeking treatment for the condition, increasing the intake of medicines, contributing to the growth of the allergic rhinitis drugs market. Additionally, the rise in awareness about allergic rhinitis due to several government initiatives are also propelling the growth of the allergic rhinitis drugs market. Besides that, initiatives by the World Allergy Organization (WAO) Allergic Rhinitis Working Group have also created awareness about better patient care for individuals with allergic rhinitis, which in turn is expected to increase the adoption of allergic rhinitis drugs over the forecast period.
However, the side effects of these drugs are discouraging people from using them though they are effective. The use of drugs such as azelastine, cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine, are olopatadine causes nose bleeds, nasal irritation, watery eyes, itchy nose and throat, insomnia, and dizziness. Apart from this, some individuals even experience rapid heartbeat, tremors, and hallucinations. These effects interfere with the daily activities of individuals, resulting in uncertainty regarding the safety and efficacy of the drugs.
Moreover, the rising investments in R&D to improve the efficiency of these drugs as well as a large number of pipeline drugs for the treatment of allergic rhinitis are expected to create fruitful opportunities for the growth of the allergic rhinitis drugs market.
North America Holds the Largest Share in the Global Allergic Rhinitis Drugs Market
Furthermore, North America holds the largest share in the global allergic rhinitis drugs market. The high awareness about the disease and high spending capacity of the population in North American countries such as the US and Canada contributes to the growth of the market in the North America region. Moreover, Europe accounted for the second-largest share in the global allergic rhinitis drugs market in 2019. The Asia Pacific has a comparatively low market share as compared to Europe and North America, but an increase in this share is expected during the forecast period due to the rise in the incidence of allergic rhinitis. Several studies suggest that there is an increase in the prevalence of allergic rhinitis in countries such as China, Japan, and India which will propel growth in this region.
Allergic Rhinitis Drugs Market: Segmentation
The report on global allergic rhinitis market covers segments such as class of drugs, and route of administration. On the basis of class of drugs, the sub-markets include immunotherapies, intranasal corticosteroids, and antihistamines. On the basis of route of administration, the sub-markets include intranasal, oral, and parenteral.
Allergic Rhinitis Drugs Market: Competitive Landscape
The report provides profiles of the companies in the market such as GlaxoSmithKline, Merck, Sanofi, Alcon, Adamis Pharmaceuticals, Belcher Pharmaceuticals, Dr. Reddy's Laboratories, Mitsubishi Tanabe Pharma, Novartis, and Pfizer.
Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-allergic-rhinitis-market
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the allergic rhinitis.
=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2026.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
No comments:
Post a Comment